Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9552862 | 0.95 | AGTR1 (0.50) | AGTR1AGTR2 | |
| SCHEMBL9553060 | 0.95 | AGTR1 (0.46) | AGTR1AGTR2 | |
| SCHEMBL9552361 | 0.94 | AGTR1 (0.47) | AGTR1AGTR2 | |
| SCHEMBL9552289 | 0.94 | AGTR1 (0.42) | AGTR1AGTR2 | |
| SCHEMBL9553655 | 0.94 | AGTR1 (0.40) | AGTR1AGTR2 | |
| SCHEMBL9552638 | 0.93 | AGTR1 (0.47) | AGTR1AGTR2 | |
| SCHEMBL9552213 | 0.93 | AGTR1 (0.41) | AGTR1AGTR2 | |
| SCHEMBL9739390 | 0.92 | AGTR1 (0.43) | AGTR1AGTR2 | |
| SCHEMBL9739416 | 0.92 | AGTR1 (0.43) | AGTR1AGTR2 | |
| SCHEMBL9552358 | 0.92 | AGTR1 (0.40) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992005161-A1 | 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-04-02 | — | — | WO | claimed |
| US-5229406-A | Treatment of glaucoma | G. D. SEARLE & CO. (US) | 1993-07-20 | — | — | US | disclosed |
| US-5140036-A | Hypotensive agents; congestive heart failure; angiotensin antagonists | G. D. SEARLE & CO. (US) | 1992-08-18 | — | — | US | disclosed |
| WO-1992005161-A1 | 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-04-02 | — | — | WO | disclosed |